DAM
HAE icon

Deltec Asset Management’s Haemonetics HAE Stock Holding History

Deltec Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30,420
Closed -$2.65M – 245
2020
Q3 		$2.65M Buy
30,420
+12,420
+69% +$1.09M 0.47% 52
2020
Q2 		$1.61M Buy
+18,000
New +$1.82M 0.34% 64

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Deltec Asset Management's HAE Position: Q4 2020 in Review

Deltec Asset Management sold out of Haemonetics (HAE) in Q4 2020, closing a stake of 30,420 shares — an estimated $2.65M sold.

Deltec Asset Management first reported a position in HAE in Q2 2020 and held it in 2 quarters. The position peaked at $2.65M in Q3 2020. 286 funds tracked by Wall St. Rank hold HAE as of Q4 2020.

  • Deltec Asset Management reported no remaining Haemonetics position as of Q4 2020 after selling out during the quarter.
  • Deltec Asset Management sold 30,420 Haemonetics shares in Q4 2020, an estimated $2.65M.
  • Deltec Asset Management first reported a position in Haemonetics in Q2 2020 and held it in 2 quarters.
  • Deltec Asset Management's Haemonetics position peaked at $2.65M in Q3 2020.
  • 286 funds tracked by Wall St. Rank held Haemonetics as of Q4 2020.

Based on Deltec Asset Management's 13F filing for Q4 2020, filed 20 Jan 2021.